The Evanthea Dementia Reversal Trial

Evanthea Dementia Reversal Trial Logo

Memory loss and Early Dementia

More than 6 million Americans are impacted by Alzheimer’s, the most common disease with dementia as the primary symptom, and about one-third of people with MCI due to Alzheimer's disease develop dementia within 5 years of diagnosis

Kemper Cognitive Wellness is ecstatic to be part of a new clinical trial! 

This is a randomized, controlled clinical trial using precision medicine, which is a novel approach involving comprehensive testing along with functional and lifestyle interventions for the treatment of mild cognitive impairment or early-stage dementia. This is a completely different way of looking at and treating memory loss that impacts so many.

A potential candidate may have any of the below early dementia and mild cognitive impairment symptoms:

  • Recently more forgetful
  • Difficulty finding words
  • Needs a list for everything
  • Lost while walking or driving
  • Difficulty with arithmetic
  • Familiar tasks are difficult
Evanthea Clinical trial Thumbnail
Yellow Play Button

Dementia Reversal Trial in Rocky River, Ohio

Applications for this trial are now open! You can apply by going to the official website to fill out the prescreening survey. After you fill out the survey your responses will be assessed by one of their team members, over the next 3-4 weeks, who will evaluate if you’re a possible candidate and contact you accordingly.

This is a revolutionary trial we believe has the potential to positively impact the future of medicine. This could change how early dementia and mild cognitive impairment are treated by looking at it from a precision medicine perspective and using lifestyle intervention.

Please visit for more information or for questions pertaining to this particular trial.